Tailored radiation beams aim to outsmart aggressive throat cancer

NCT ID NCT06234748

Ongoing Disease control Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a personalized radiation plan for people with HPV-related throat cancer that is considered high-risk. Using advanced scans (MRI and PET), doctors adjust the radiation dose to target the most aggressive parts of the tumor. The goal is to see if this approach is safe and effective, potentially reducing side effects while improving cancer control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy
What this could lead to: If successful, this approach could personalize radiation doses for high-risk HPV-related throat cancer, potentially improving tumor control while reducing side effects.
What could go wrong: This is a small pilot study with only 19 participants, so results may not apply broadly. The higher radiation dose could increase toxicity, and the imaging-guided boost may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papillomavirus-related squamous cell carcinoma oropharynx cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV-RELATED CARCINOMA OROPHARYNX CANCER

Contacts and locations

Locations

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.